Wie hoch ist der Preis für PacificHealth Laboratories, Inc. (PHLI)

Preis für PacificHealth Laboratories, Inc. (PHLI) ist $0.0001

Wie hoch ist die Marktkapitalisierung für PacificHealth Laboratories, Inc. (PHLI)

Marktkapitalisierung für PacificHealth Laboratories, Inc. (PHLI) ist $438.31K

PacificHealth Laboratories, Inc. (PHLI) Dividendenrendite

PacificHealth Laboratories, Inc. (PHLI) specializes in developing and marketing nutritional products designed to boost overall health and enhance athletic performance for consumers both within the United States and internationally. The company's offerings predominantly target key aspects of athletic performance, such as optimal sports performance, proper hydration, sustained energy (fueling), and efficient muscle recovery. PHLI's product line includes notable items like ENDUROX R4, a drink formulated for muscle recovery; ACCELERADE, a protein-powered sports beverage; energy gels such as ACCEL GEL and 2ND SURGE; the exercise supplement ENDUROX EXCEL; and Body Glove Surge. Additionally, they provide ACCELERADE HYDRO, a specific formulation for less intense workouts, which supports hydration, energy, and recovery before, during, and after physical activity. Reaching consumers through diverse distribution channels, PHLI's products are available in sports specialty and natural product retailers and chains, as well as directly through their official website. PacificHealth Laboratories, Inc. was founded in 1995 and is headquartered in Matawan, New Jersey.

Jahr	Dividendenrendite	ändert
Nicht genügend Daten für die angegebenen Daten.

Jahr

Dividendenrendite

ändert

Nicht genügend Daten für die angegebenen Daten.

Unternehmen	Dividendenrendite	Land
The Procter & Gamble Company PG.US	2.97%	US
L'Oréal S.A. OR.PA	1.88%	FR
Colgate-Palmolive Company CL.US	2.30%	US
Hindustan Unilever Limited HINDUNILVR.NS	1.95%	IN
Henkel AG & Co. KGaA HEN.DE	0.00%	DE

Unternehmen

Dividendenrendite

Land